Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Nonanol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.93 |
| ▸ | TSHR | P16473 | 4/20 | 0.93 |
| ▸ | LMNA | P02545 | 3/20 | 0.93 |
| ▸ | MEN1 | O00255 | 2/20 | 0.93 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.93 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.86 |
| ▸ | THRB | P10828 | 2/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cetostearyl Alcohol SCHEMBL1643143 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Myristyl Alcohol SCHEMBL2046092 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Cetyl Alcohol SCHEMBL1101785 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Triacontanol SCHEMBL5609342 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Decanol SCHEMBL10594393 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Alcohol SCHEMBL5138742 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Cetyl Alcohol SCHEMBL873050 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Docosanol SCHEMBL4958624 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Undecanol SCHEMBL4656406 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A | |
| Alcohol SCHEMBL872545 | 1.00 | ALDH1A1 (0.93) | ALDH1A1TSHRLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1069824-B1 | ORAL ANTIMICROBIAL AND ANTI-ODOUR COMPOSITIONS | INNOSCENT LTD (IL) | 2003-09-17 | — | — | EP | claimed |
| US-4258219-A | Process for producing hydroquinone | MITSUI TOATSU CHEMICALS, INC. (JP) | 1981-03-24 | — | — | US | claimed |
| US-20210317056-A1 | Wax Ethers and Related Methods | INTERNATIONAL FLORA TECHNOLOGIES, LTD. | 2021-10-14 | — | — | US | disclosed |
| EP-3773449-A1 | WAX ETHERS AND RELATED METHODS | International Flora Technologies, Ltd. (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20200231524-A1 | Wax Ethers and Related Methods | INTERNATIONAL FLORA TECHNOLOGIES, LTD. | 2020-07-23 | — | — | US | disclosed |
| US-10633318-B2 | Wax ethers and related methods | INTERNATIONAL FLORA TECHNOLOGIES, LTD. (US) | 2020-04-28 | — | — | US | disclosed |
| WO-2019191069-A1 | WAX ETHERS AND RELATED METHODS | INTERNATIONAL FLORA TECHNOLOGIES, LTD. (US) | 2019-10-03 | — | — | WO | disclosed |
| US-20190292121-A1 | Wax Ethers and Related Methods | INTERNATIONAL FLORA TECHNOLOGIES, LTD. | 2019-09-26 | — | — | US | disclosed |
| US-10155905-B2 | Liquid crystal compound having vinylene group, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2018-12-18 | — | — | US | disclosed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| US-9593094-B2 | Liquid crystal medium, optical device, and liquid crystal compound | JNC CORPORATION (JP) | 2017-03-14 | — | — | US | disclosed |
| CN-105906490-A | LIQUID CRYSTAL COMPOUND HAVING VINYLENE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | 捷恩智株式会社 | 2016-08-31 | — | — | CN | disclosed |
| US-20160244670-A1 | LIQUID CRYSTAL COMPOUND HAVING VINYLENE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-08-25 | — | — | US | disclosed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| US-20160002536-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE, AND LIQUID CRYSTAL COMPOUND | JNC PETROCHEMICAL CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| WO-2010135660-A2 | IONIC LIQUID MEDIATED SOL-GEL SORBENTS | UNIVERSITY OF SOUTH FLORIDA (US) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002536-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE, AND LIQUID CRYSTAL COMPOUND | HCN1, HCN3, HCN2 | ALDH1A1 1702/4885TSHR 2826/4885LMNA 2150/4885 |
| US-10155905-B2 | Liquid crystal compound having vinylene group, liquid crystal composition and liquid crystal display device | OCIAD1, LEF1, CPNE4 | ALDH1A1 1258/4885TSHR 3752/4885LMNA 1996/4885 |
| US-20160244670-A1 | LIQUID CRYSTAL COMPOUND HAVING VINYLENE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | OCIAD1, OCIAD2, PIEZO1 | ALDH1A1 1407/4885TSHR 4444/4885LMNA 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.